JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, vol.19, no.4, pp.523-528, 2006 (SCI-Expanded, Scopus)
Objectives: To evaluate the efficacy and safety of oral alendronate on bone mineral density (BMD) in children and adolescents with osteoporosis.